| Similar Articles |
|---|
 |
Nursing
July 2010
Susan Simmons |
A delicate balance: Detecting thyroid disease An estimated 27 million Americans have been diagnosed with thyroid disease, and another 13 million have undiagnosed thyroid disorders.   |
American Family Physician
May 15, 2006
Bindra & Braunstein |
Thyroiditis Thyroiditis is an inflammation of the thyroid gland that may be painful and tender when caused by infection, radiation, or trauma, or painless when caused by autoimmune conditions, medications, or an idiopathic fibrotic process. |
American Family Physician
February 1, 2002
Diane K. Shrier |
Subclinical Hyperthyroidism: Controversies in Management Subclinical hyperthyroidism is an increasingly recognized entity that is defined as a normal serum free thyroxine and free triiodothyronine levels with a thyroid-stimulating hormone level suppressed below the normal range and usually undetectable... |
Nursing
October 2005
Susan Simmons Holcomb |
Detecting Thyroid Disease Thyroid dysfunction can mimic signs and symptoms of aging. Find out how to recognize problems early, then learn about treatment and ways to manage symptoms. |
American Family Physician
November 15, 2001
William J. Hueston |
Treatment of Hypothyroidism Because hypothyroidism is so common, family physicians need to know how to diagnose the disorder and select appropriate thyroid hormone replacement therapy... |
American Family Physician
October 15, 2005
Wilson & Curry |
Subclinical Thyroid Disease The management of subclinical thyroid dysfunction is controversial, but there is good evidence that subclinical hypothyroidism is associated with progression to overt disease. |
American Family Physician
January 15, 2003
Welker & Orlov |
Thyroid Nodules A thyroid nodule is a palpable swelling in a thyroid gland with an otherwise normal appearance. Thyroid nodules are common and may be caused by a variety of thyroid disorders. While most are benign, about 5 percent of all palpable nodules are malignant. |
Nursing
June 2010
Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
American Family Physician
December 1, 2003
Lyle A. Siddoway |
Amiodarone: Guidelines for Use and Monitoring Amiodarone is a potent antiarrhythmic agent that is used to treat ventricular arrhythmias and atrial fibrillation. The drug prevents the recurrence of life-threatening ventricular arrhythmias and produces a modest reduction of sudden deaths in high-risk patients. |
Nursing
March 2012
Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
Nurse Practitioner
February 2011
Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
Nursing
February 2009
Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
Nursing
June 2011
Cahill & Armstrong |
Caring for an adult with a malignant primary brain tumor Pprimary brain tumors are relatively uncommon, occurring in an estimated 63,000 patients in the united states each year. |
Nursing
May 2012
Tim Blake |
Three Medication Pathways for Bipolar Disorder No matter where you work, you're likely to care for patients with bipolar disorder, which affects about 2.6% of people age 18 and older per year. |
Nurse Practitioner
August 2011
Davis et al. |
Supportive approaches for Alzheimer Disease Alzheimer disease accounts for almost 80% of all dementia diagnoses. Currently, more than 5 million Americans suffer from this debilitating illness, with the highest prevalence in the oldest age groups. |
Nurse Practitioner
February 2012
Jennifer M. Belavic |
Annual drug update 2011 in review Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice |
American Journal of Nursing
July 2011
Brodkey et al. |
Living Well with Multiple Sclerosis Improvements in magnetic resonance imaging and the advent of disease-modifying therapies in the past 15 years have changed the diagnosis and treatment of multiple sclerosis |
American Family Physician
December 1, 2000
Cristen Rhodes Wall |
Myxedema Coma: Diagnosis and Treatment Myxedema coma, the extreme manifestation of hypothyroidism, is an uncommon but potentially lethal condition... |
Nursing
April 2012
Elliott et al. |
Managing alcohol withdrawal in hospitalized patients A focused nursing assessment is critical in identifying the potential for alcohol withdrawal symptoms in all hospitalized patients. This article discusses how to assess patients at risk and how to use these assessment findings as a basis for nursing interventions. |
Pharmaceutical Executive
July 1, 2011
Dickmeyer & Rosenbeck |
From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition? |
The Motley Fool
August 10, 2010
Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
Nurse Practitioner
July 2011
Kass-Wolff & Fisher |
Menopause and the Hormone Controversy: Clarification or Confusion? Hormone therapy in perimenopause and menopause remains a controversial and often confusing management strategy for healthcare providers. To assist in providing women quality healthcare, recently published new guidelines help provide direction for NPs. |
Nursing
March 2010
Peg Gray-Vickrey |
Gathering pearls of knowledge for assessing older adults If you attended nursing school more than 10 years ago, you may have received limited education about gerontological nursing. But as baby boomers age, this is becoming an increasingly important area of nursing practice. |
American Family Physician
April 15, 2004
Kathy Soch, M.D. |
Diary from a Week in Practice Adjusting thyroid doses... Assessing driving ability in the office setting... etc. |
The Motley Fool
September 7, 2010
Luke Timmerman |
Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too. |
American Journal of Nursing
June 2011
Karen Roush |
Menopausal Hormone Therapy: What We Know Now This article describes the findings and limitations of the major research thus far on hormone therapy. |
Pharmaceutical Executive
May 1, 2014
Ben Comer |
2014 Brand of the Year Brand of the Year recipients for 2014 are Copaxone, a mainstay treatment for multiple sclerosis, and KORLYM for diseases driven by excess production of the metabolic hormone, cortisol. We profile the journey of both drugs. |
American Family Physician
February 1, 2003 |
Thyroid Nodules What is a thyroid nodule?... Who gets thyroid nodules and why?... What are the symptoms of thyroid nodules?... How can my doctor tell if I have thyroid nodules?... How are thyroid nodules treated?... Where can I get more information? |
Health
June 2006
Melanie Haiken |
Hypothyroidism: How to find answers If you suspect you have hypothyroidism, match your symptoms to those listed in this article. |
Pharmaceutical Executive
September 1, 2012
Robin Hertz |
The Endless Treadmill of End-of-Life Care Bending the cost curve back to valuing the cycle of life. |
The Motley Fool
September 8, 2010
Brian Orelli |
You Must Realize This Drug Works by Now Vertex concludes its phase 3 trials with another win. |
The Motley Fool
March 31, 2011
Brian Orelli |
Hepatitis C Drugs Heat Up The current hepatitis C drugs stink. Who's ahead in the race to find new ones? |
Pharmaceutical Executive
April 1, 2012
Feam & Lagus |
Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help. |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
CIO
October 29, 2015
Martha Heller |
Amgen uses algorithms to venture into digital healthcare A senior vice president of global marketing and commercial development, says she's working with the CIO to set up a digital healthcare organization that can help physicians better predict how patients will respond to therapies. |
Pharmaceutical Executive
June 1, 2014
O'Connor et al. |
Challenges to the Specialty Business Model New constraints require new solutions. Innovative, value-based pricing models will be critical to securing reimbursement and continued market access of high-price drugs. |
Pharmaceutical Executive
October 1, 2011 |
Patient Advocacy: The Last 30 Years The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal. |
Pharmaceutical Executive
December 1, 2013
Vansgaard et al. |
Develop Drugs for People, Not Just Bodies A patient-centric approach to drug development delivers the benefits that actually create value |
The Motley Fool
August 11, 2010
Brian Orelli |
Dang! This Drug Is Shining Brighter Vertex illuminates telaprevir's additional benefit in treating hepatitis C patients. |
Pharmaceutical Executive
January 1, 2013
Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
The Motley Fool
February 24, 2011
Brian Orelli |
Profit From Personalized Medicine Pfizer's drug works well, but consider these companies instead. |
Pharmaceutical Executive
June 1, 2014
Ben Comer |
Take as Directed: From Force to Finesse in Promoting Adherence Healthcare players tout patient education and engagement as the keys to better drug adherence rates. Patients agree, as long as that translates to convenient and affordable access to therapy. |
Chemistry World
May 20, 2015
Mark R StJ Foreman |
The nuclear danger of iodine Certain isotopes of iodine are harmful. In both the Fukushima and the 1986 Chernobyl accidents, volatile iodine species were released into the environment with tellurium. |
Health
June 2006
Melanie Haiken |
Treatment Options for Hypothyroidism There is no one-size-fits-all treatment for hypothyroidism. It may take a few trips to the doctor to get the right remedy, and over time, your prescribed medication may change. Here's a brief look at the possibilities. |
BusinessWeek
June 9, 2009
John Carey |
Giving Patients the Data They Need A growing effort by doctors, insurers, and politicians helps people make better-informed medical decisions |
Pharmaceutical Executive
May 1, 2009
Maryann Kuzel |
Weathering the Storm Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market. |
Pharmaceutical Executive
September 1, 2012
Al Topin |
Doctors' Words No Longer Gospel In the digital age, physicians don't call the shots when it comes to healthcare guidance. Marketers must appeal to multiple sources in seeking ways to garner patient adherence and loyalty. |
Nursing Management
March 2010
Becker & Schmidtke |
All along the watchtower: Suicide risk screening, a pilot study Patients will continue to die if healthcare organizations don't take action and appropriately assess patients at risk for suicide in general hospitals. |
